Intuitive Surgical (NASDAQ:ISRG) VP Fredrik Widman Sells 1,089 Shares of Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) VP Fredrik Widman sold 1,089 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, September 15th. The shares were sold at an average price of $374.44, for a total value of $407,765.16. Following the transaction, the vice president directly owned 1,026 shares in the company, valued at approximately $384,175.44. The trade was a 51.49% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Intuitive Surgical Trading Up 1.4%

Shares of Intuitive Surgical stock opened at $382.29 on Thursday. The company has a market capitalization of $135.06 billion, a P/E ratio of 43.79, a price-to-earnings-growth ratio of 2.85 and a beta of 1.47. The stock has a fifty day simple moving average of $373.52 and a 200 day simple moving average of $420.74. Intuitive Surgical, Inc. has a 12-month low of $328.57 and a 12-month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, beating the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.The business had revenue of $2.89 billion for the quarter, compared to analysts’ expectations of $2.83 billion. During the same period last year, the business earned $1.81 EPS. The business’s revenue was up 18.4% on a year-over-year basis. On average, analysts predict that Intuitive Surgical, Inc. will post 8.87 EPS for the current year.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the stock. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Intuitive Surgical in a research report on Friday, August 14th. Piper Sandler restated an “overweight” rating on shares of Intuitive Surgical in a research note on Friday, August 21st. JPMorgan Chase & Co. reduced their target price on Intuitive Surgical from $550.00 to $450.00 and set an “overweight” rating for the company in a report on Friday, July 17th. BTIG Research reaffirmed a “buy” rating and set a $469.00 price target on shares of Intuitive Surgical in a research report on Tuesday, September 8th. Finally, Sanford C. Bernstein reiterated an “outperform” rating on shares of Intuitive Surgical in a report on Wednesday, August 12th. Twenty-two research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $508.68.

Institutional Investors Weigh In On Intuitive Surgical

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Deutsche Bank AG lifted its stake in shares of Intuitive Surgical by 9.6% during the 4th quarter. Deutsche Bank AG now owns 1,522,191 shares of the medical equipment provider’s stock valued at $862,108,000 after buying an additional 132,966 shares in the last quarter. Jag Capital Management LLC purchased a new position in Intuitive Surgical in the 4th quarter valued at approximately $18,771,000. Plato Investment Management Ltd bought a new stake in Intuitive Surgical during the 2nd quarter valued at $4,315,000. Sycomore Asset Management bought a new stake in Intuitive Surgical during the 4th quarter valued at $10,730,000. Finally, Hikari Power Ltd bought a new stake in Intuitive Surgical during the 2nd quarter valued at $5,619,000. 83.64% of the stock is currently owned by institutional investors.

Key Headlines Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive Surgical received a European CE mark expanding the da Vinci SP system’s approved use to transvaginal gynecologic procedures. The authorization opens a new women’s-health market and could broaden the platform’s long-term growth runway in Europe. ISRG Wins EU Nod to Expand da Vinci SP in Gynecologic Procedures
• Positive Sentiment: A meta-analysis covering approximately 14 million procedures reported better perioperative outcomes for da Vinci surgery across 13 common conditions compared with laparoscopic and open surgery. The findings may support broader adoption of robotic-assisted surgery. ISRG’s da Vinci Study Shows Better Outcomes Across 13 Common Conditions
• Positive Sentiment: Analyst commentary remains generally constructive, with recent Buy ratings and a reported median price target of $574, substantially above the stock’s current trading level. Investors are also watching the company’s strong procedure-volume trends and prior quarterly revenue growth of more than 18%.
• Positive Sentiment: Social-media discussions identified a potential double-bottom pattern, fueling speculation that the recent decline could precede a rebound if third-quarter results show continued growth in da Vinci procedures and system installations. Opinions on Recent Price Decline Ahead of Q3 Earnings

About Intuitive Surgical

Intuitive Surgical, Inc is a medical technology company that develops and manufactures robotic-assisted surgical systems and related products. Its technology is designed to support surgeons during minimally invasive procedures by providing enhanced visualization, instrument control and dexterity.

The company’s principal product is the da Vinci Surgical System, which is used across a range of specialties, including general surgery, urology, gynecology, cardiothoracic surgery and other procedures.